A series of pregnancies in women with inherited metabolic disease

Janneke G. Langendonk(Erasmus MC), Elaine Murphy(National Hospital for Neurology and Neurosurgery), Francois Karstens(Erasmus MC), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Catherine Williamson(Imperial College London), Charlé Maritz(National Hospital for Neurology and Neurosurgery), Lindsay Angus(Erasmus MC), Jonathan C. P. Roos(University of Cambridge), Robin Lachmann(University College London), Monique Williams(Erasmus MC), Johannes BC de Klerk(Erasmus MC)
Journal of Inherited Metabolic Disease
September 14, 2011
10.1007/s10545-011-9389-2
Cited by 81

Related Papers

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
|The Lancet|2010|905
Intrahepatic cholestasis of pregnancy
|World Journal of Gastroenterology|2009|675
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Whole-genome sequencing of patients with rare diseases in a national health system
|Nature|2020|587
Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders
|Science|2014|548